APA (7th ed.) Citation

MS, S., JH, Y., CH, J., JY, H., WJ, L., MS, K., & JY, P. (2012). The Duration of Sulfonylurea Treatment Is Associated with [beta]-Cell Dysfunction in Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics, 14(11), 1033. https://doi.org/10.1089/dia.2012.0144

Chicago Style (17th ed.) Citation

MS, Shin, Yu JH, Jung CH, Hwang JY, Lee WJ, Kim MS, and Park JY. "The Duration of Sulfonylurea Treatment Is Associated with [beta]-Cell Dysfunction in Patients with Type 2 Diabetes Mellitus." Diabetes Technology & Therapeutics 14, no. 11 (2012): 1033. https://doi.org/10.1089/dia.2012.0144.

MLA (9th ed.) Citation

MS, Shin, et al. "The Duration of Sulfonylurea Treatment Is Associated with [beta]-Cell Dysfunction in Patients with Type 2 Diabetes Mellitus." Diabetes Technology & Therapeutics, vol. 14, no. 11, 2012, p. 1033, https://doi.org/10.1089/dia.2012.0144.